CBD shows promising potential for concussion recovery in animal and early human research, but there are no completed, large-scale clinical trials proving it works. The honest answer right now: the science is encouraging but incomplete. Most of the evidence comes from lab studies, animal models, and a handful of very small human case reports. Several major trials are underway, including ones funded by the NFL and involving retired NHL players, that should provide much clearer answers in the coming years.
That said, there are specific biological reasons researchers think CBD could help, and early data on related symptoms like headaches, sleep problems, and mood changes is worth understanding if you’re weighing your options.
Why Researchers Think CBD Could Help
After a concussion, the brain enters a cascade of harmful processes. Cells release excessive amounts of a chemical messenger called glutamate, which overstimulates neurons and can damage or kill them. At the same time, inflammation ramps up and unstable molecules called free radicals accumulate, causing further injury to brain tissue. This secondary damage, happening in the hours and days after the initial impact, is often what drives lingering symptoms.
CBD interacts with the body’s endocannabinoid system, a network of receptors that helps regulate inflammation, pain signaling, and neural repair. In animal studies, CBD has reduced brain injury following stroke by dialing down inflammation and limiting the toxic effects of glutamate flooding. It also appears to act as an antioxidant, neutralizing some of the free radical damage. These mechanisms are directly relevant to what happens in the brain after a concussion, which is why the compound has attracted serious research interest.
What the Human Evidence Actually Shows
As of now, no blinded, randomized human clinical trials on CBD for concussion have been completed and published. That’s the most important thing to know. The studies that do exist are small and preliminary.
A case series of four women with persistent post-concussion symptoms showed improvements in cardiovascular function and concussion-related symptoms when given CBD at doses ranging from 50 to 400 mg daily. One group received a combination product with a 20:1 ratio of CBD to THC. These results are interesting but far too small to draw firm conclusions from.
Several larger studies are now in progress. The NHL Alumni Association has been developing a double-blind, randomized study of over 100 retired players to assess CBD’s benefit for concussion recovery. The NFL has funded two separate clinical studies: one looking at cannabinoids for pain and recovery from sports injuries, and another specifically examining neuroprotection from concussion in contact sports. A separate trial is also recruiting participants to study CBD as a treatment for PTSD occurring alongside traumatic brain injury, relevant for military veterans. These trials should dramatically improve the quality of evidence available.
Post-Concussion Headaches
Headaches are the single most common symptom after a concussion, and for many people they become chronic. Migraine-type headaches are the dominant pattern, showing up in 49 to 90 percent of both military service members and civilians with concussion or traumatic brain injury. This is where CBD’s existing pain research becomes relevant.
Animal studies have consistently shown that CBD reduces both inflammatory and neuropathic pain. A retrospective study found that medical marijuana reduced headache frequency in patients, though side effects varied by product type. CBD alone has not been directly tested in humans specifically for headache pain, but a prescription product combining CBD with THC has produced significant pain relief in multiple clinical studies. The gap between animal results and human proof remains the main limitation.
Sleep Disruption After Concussion
Poor sleep is one of the most frustrating parts of concussion recovery, and it creates a vicious cycle: the brain needs quality rest to heal, but the injury itself disrupts sleep patterns. CBD has some of the more encouraging human data in this area, though not specifically in concussion patients.
A case series evaluating CBD for insomnia in people with PTSD showed decreased sleep disturbances as measured by a standard sleep quality scale. Another study on treatment-resistant PTSD patients found that cannabinoid treatment reduced nightmare intensity while improving both sleep quality and total sleep time. A synthetic cannabinoid tested in a more controlled crossover study increased sleep efficiency and total sleep time, though it also increased the time it took to fall asleep initially. These findings suggest CBD may help with the kind of fragmented, restless sleep that often follows a concussion, but dedicated trials in concussion patients are still needed.
Full-Spectrum vs. CBD Isolate
If you’re considering CBD, the type of product may matter. A 2024 animal study compared full-spectrum CBD extract (which contains small amounts of other cannabis compounds) against pure CBD isolate in a model of chronic, low-grade inflammation. The full-spectrum product reversed inflammation-driven depressive behavior and reduced lethargy at both doses tested. The CBD isolate did neither.
This aligns with a concept sometimes called the “entourage effect,” where the various compounds in hemp work together more effectively than CBD alone. For something like post-concussion recovery, where inflammation plays a central role, full-spectrum products may offer more benefit. One caveat: the full-spectrum product also showed a trend toward increasing anxiety-like behavior in the same study, so the picture isn’t entirely one-sided.
Dosing Is Still Uncertain
There is no established CBD dose for concussion recovery. The small case series on post-concussion symptoms used doses between 50 and 400 mg daily. A current dose-escalation study protocol is testing a much wider range, from 5 mg per kilogram of body weight per day up to 30 mg per kilogram per day, escalating every two weeks. For a 150-pound person, that translates to roughly 340 mg to over 2,000 mg daily at the upper end.
Broader CBD research shows that oral doses from 100 mg to 4,500 mg daily have been administered safely in various studies. But “safe” and “effective” are different things, and higher doses carry greater risk of side effects and drug interactions. Starting low and increasing gradually is the general approach used in clinical research.
Drug Interactions to Watch For
CBD is processed by the same liver enzymes that break down many common medications, which can cause drugs to build up to higher levels in your blood than expected. This is especially relevant after a concussion, when you might be taking other medications.
If you take blood thinners like warfarin, CBD can amplify their effect. One documented case required a 30 percent reduction in warfarin dose after the patient started CBD, with excessive bleeding as the initial warning sign. CBD also interacts with several anti-seizure medications, including some prescribed after more severe brain injuries. It can increase levels of lamotrigine, a medication sometimes used for mood stabilization and seizure prevention, by interfering with the enzyme that clears it from the body.
These interactions don’t mean you can’t use CBD, but they do mean combining it with prescription medications requires careful monitoring. The more medications you take, the more important this becomes.
The Bottom Line on Current Evidence
The biological rationale for CBD in concussion recovery is solid. It targets inflammation, oxidative damage, and pain signaling, all of which drive post-concussion symptoms. Animal research supports these mechanisms consistently. But the human clinical data specific to concussion is extremely limited, consisting of case reports and small series rather than rigorous trials. The NFL and NHL-backed studies currently underway represent the first serious attempts to answer this question with the kind of evidence that would change medical practice. Until those results arrive, CBD remains a plausible but unproven option for concussion recovery.